Index RUT P/E - EPS (ttm) -0.49 Insider Own 32.10% Shs Outstand 66.23M Perf Week -6.65%
Market Cap 542.15M Forward P/E 8.54 EPS next Y 0.77 Insider Trans -0.11% Shs Float 45.06M Perf Month -1.64%
Enterprise Value 912.57M PEG - EPS next Q 0.17 Inst Own 51.43% Short Float 3.62% Perf Quarter -11.76%
Income -31.61M P/S 0.95 EPS this Y 17.35% Inst Trans 5.72% Short Ratio 3.80 Perf Half Y -28.88%
Sales 567.70M P/B 2.95 EPS next Y 34.35% ROA -4.26% Short Interest 1.63M Perf YTD -37.14%
Book/sh 2.24 P/C 23.78 EPS next 5Y 17.01% ROE -19.79% 52W High 14.38 -54.10% Perf Year 0.30%
Cash/sh 0.28 P/FCF 22.66 EPS past 3/5Y - -113.92% ROIC -6.82% 52W Low 6.02 9.63% Perf 3Y -16.67%
Dividend Est. - EV/EBITDA 11.19 Sales past 3/5Y 9.98% 11.00% Gross Margin 66.13% Volatility 5.04% 4.53% Perf 5Y -
Dividend TTM - EV/Sales 1.61 EPS Y/Y TTM -42.76% Oper. Margin 5.62% ATR (14) 0.32 Perf 10Y -
Dividend Ex-Date Mar 26, 2004 Quick Ratio 0.89 Sales Y/Y TTM 8.60% Profit Margin -5.57% RSI (14) 44.51 Recom 1.50
Dividend Gr. 3/5Y - - Current Ratio 1.43 EPS Q/Q 44.52% SMA20 -2.78% Beta 0.84 Target Price 12.25
Payout - Debt/Eq 2.40 Sales Q/Q -4.31% SMA50 -1.61% Rel Volume 0.86 Prev Close 6.81
Employees 930 LT Debt/Eq 2.13 Earnings May 06 BMO SMA200 -30.96% Avg Volume 430.26K Price 6.60
IPO Feb 11, 2021 Option/Short Yes / Yes EPS/Sales Surpr. 225.20% 0.95% Trades
Volume 369,212 Change -3.08%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-07-25 Initiated Cantor Fitzgerald
Overweight
$12
Dec-17-24 Upgrade JP Morgan
Underweight → Neutral
$12 → $13
Dec-07-23 Upgrade Canaccord Genuity
Hold → Buy
$7
Aug-09-23 Upgrade Craig Hallum
Hold → Buy
$4 → $6
Nov-22-22 Downgrade Craig Hallum
Buy → Hold
Nov-09-22 Downgrade JP Morgan
Overweight → Underweight
Nov-09-22 Downgrade Canaccord Genuity
Buy → Hold
$18 → $6
Mar-15-22 Initiated Craig Hallum
Buy
$30
Nov-15-21 Resumed Morgan Stanley
Overweight
$20
Nov-10-21 Resumed JP Morgan
Overweight
$25
Jul-01-21 Downgrade Goldman
Buy → Neutral
$20 → $19
Mar-08-21 Initiated Morgan Stanley
Overweight
$18
Mar-08-21 Initiated JP Morgan
Overweight
$17
Mar-08-21 Initiated Goldman
Buy
$19
Mar-08-21 Initiated Canaccord Genuity
Buy
$23
Show Previous Ratings
Jun-13-25 08:30AM
May-07-25 03:09AM
01:21AM
(Thomson Reuters StreetEvents)
May-06-25 08:45AM
07:50AM
(Associated Press Finance)
07:30AM
Loading…
07:30AM
May-05-25 10:10AM
Apr-28-25 08:00AM
Apr-24-25 01:25AM
Apr-17-25 08:21AM
Apr-03-25 01:09PM
Mar-31-25 09:55AM
Mar-28-25 11:06AM
Mar-17-25 12:00PM
Mar-12-25 03:08AM
(Thomson Reuters StreetEvents) -6.76%
03:04AM
Loading…
03:04AM
Mar-11-25 08:45AM
07:52AM
(Associated Press Finance)
07:30AM
Feb-28-25 07:30AM
Jan-07-25 08:00AM
Jan-03-25 08:05AM
Jan-02-25 08:00AM
Dec-23-24 09:40AM
Dec-06-24 09:55AM
Nov-06-24 02:43AM
(Thomson Reuters StreetEvents)
02:14AM
Nov-05-24 08:45AM
07:41AM
(Associated Press Finance)
07:30AM
09:40AM
Loading…
Nov-04-24 09:40AM
07:09AM
Oct-29-24 07:30AM
Oct-15-24 04:01PM
(Investor's Business Daily)
Oct-09-24 05:03PM
Oct-01-24 09:00AM
Aug-29-24 07:09AM
Aug-07-24 04:15PM
Aug-06-24 07:30AM
Jul-30-24 07:30AM
Jun-05-24 10:17AM
May-23-24 06:42AM
May-09-24 07:29AM
May-08-24 12:28PM
03:19AM
May-07-24 11:41PM
(Thomson Reuters StreetEvents) +28.00%
07:00AM
Apr-29-24 07:30AM
Mar-13-24 08:48AM
Mar-12-24 10:20PM
(Thomson Reuters StreetEvents) +5.46%
09:11AM
07:30AM
Mar-04-24 08:00AM
Jan-18-24 04:15PM
Jan-12-24 04:15PM
Dec-19-23 04:30PM
Dec-06-23 08:00AM
Nov-27-23 01:33AM
Nov-12-23 09:02AM
Nov-07-23 07:59AM
07:00AM
Oct-31-23 07:00AM
Oct-25-23 10:48AM
Sep-28-23 07:43AM
Sep-19-23 09:52PM
Sep-06-23 04:30PM
Aug-16-23 09:02AM
Aug-10-23 08:09AM
(American City Business Journals) +11.74%
Aug-08-23 10:02PM
(Thomson Reuters StreetEvents) +14.12%
+5.41%
07:30AM
Aug-04-23 08:30AM
Aug-01-23 05:35PM
Jun-23-23 06:35PM
May-25-23 06:38AM
May-23-23 07:30AM
May-18-23 12:07PM
May-17-23 08:33AM
(Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM
May-15-23 05:33PM
May-11-23 07:00AM
May-10-23 09:00AM
May-03-23 08:30AM
Apr-08-23 08:55AM
Apr-05-23 10:52AM
08:00AM
07:38AM
Mar-31-23 07:30AM
07:00AM
Mar-30-23 04:51AM
Mar-29-23 08:55AM
Mar-20-23 10:16AM
Mar-16-23 08:30AM
Feb-28-23 07:30AM
Jan-27-23 02:49PM
(American City Business Journals)
Jan-14-23 03:14PM
Jan-04-23 07:00AM
Dec-27-22 02:53PM
(American City Business Journals)
Dec-09-22 11:58AM
(American City Business Journals)
Nov-28-22 10:34PM
(American City Business Journals) -20.41%
Nov-21-22 05:15PM
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bartholdson John A. Director Jun 06 '25 Option Exercise 0.00 7,575 0 79,620 Jun 10 05:49 PM Bartholdson John A. Director Jun 02 '25 Option Exercise 0.00 26,493 0 72,045 Jun 05 09:22 AM SUTTER MARTIN P Director Jun 02 '25 Option Exercise 0.00 26,493 0 85,241 Jun 04 09:30 PM STALNECKER SUSAN M Director Jun 02 '25 Option Exercise 0.00 26,493 0 105,957 Jun 04 09:30 PM NOHRA GUY P Director Jun 02 '25 Option Exercise 0.00 26,493 0 126,610 Jun 04 09:30 PM NEELS GUIDO J Director Jun 02 '25 Option Exercise 0.00 26,493 0 85,241 Jun 04 09:30 PM McMurry-Heath Michelle Director Jun 02 '25 Option Exercise 0.00 26,493 0 74,698 Jun 04 09:30 PM Ladone Mary Kay Director Jun 02 '25 Option Exercise 0.00 26,493 0 78,981 Jun 04 09:30 PM HAWKINS WILLIAM A Director Jun 02 '25 Option Exercise 0.00 26,493 0 257,851 Jun 04 09:29 PM Beyer Pat Director Jun 02 '25 Option Exercise 0.00 26,493 0 76,436 Jun 04 09:29 PM Singleton Mark Leonard SVP & CFO Apr 11 '25 Sale 7.57 3,875 29,334 141,088 Apr 15 05:50 PM D'Adamio Anthony SVP & General Counsel Apr 11 '25 Sale 7.57 2,958 22,392 131,416 Apr 15 05:50 PM CHURCH KATRINA J SVP & Chief Compliance Officer Apr 11 '25 Sale 7.57 1,283 9,712 55,557 Apr 15 05:49 PM D'Adamio Anthony Officer Apr 11 '25 Proposed Sale 9.51 4,000 38,040 Apr 11 05:39 PM Singleton Mark Leonard SVP & CFO Apr 10 '25 Option Exercise 0.00 13,000 0 144,963 Apr 11 05:31 PM D'Adamio Anthony SVP & General Counsel Apr 10 '25 Option Exercise 0.00 9,925 0 134,374 Apr 11 05:30 PM CHURCH KATRINA J SVP & Chief Compliance Officer Apr 10 '25 Option Exercise 0.00 4,300 0 56,840 Apr 11 05:30 PM Singleton Mark Leonard SVP & CFO Mar 24 '25 Sale 9.79 5,479 53,639 131,963 Mar 25 05:37 PM Singleton Mark Leonard Officer Mar 24 '25 Proposed Sale 9.80 12,000 117,600 Mar 24 04:50 PM Singleton Mark Leonard SVP & CFO Mar 21 '25 Option Exercise 0.00 18,625 0 137,442 Mar 21 05:24 PM CHURCH KATRINA J SVP & Chief Compliance Officer Mar 17 '25 Sale 9.75 1,018 9,926 52,540 Mar 18 05:34 PM D'Adamio Anthony SVP & General Counsel Mar 17 '25 Sale 9.75 2,615 25,496 124,449 Mar 18 05:33 PM CHURCH KATRINA J SVP & Chief Compliance Officer Mar 14 '25 Option Exercise 0.00 3,456 0 53,558 Mar 14 07:06 PM D'Adamio Anthony SVP & General Counsel Mar 14 '25 Option Exercise 0.00 8,886 0 127,064 Mar 14 07:05 PM Singleton Mark Leonard SVP & CFO Feb 18 '25 Sale 10.19 6,498 66,215 118,817 Feb 20 07:01 PM D'Adamio Anthony SVP & General Counsel Feb 18 '25 Sale 10.19 4,380 44,632 118,178 Feb 20 07:00 PM CHURCH KATRINA J SVP & Chief Compliance Officer Feb 18 '25 Sale 10.19 1,537 15,662 50,102 Feb 20 07:00 PM Singleton Mark Leonard SVP & CFO Feb 15 '25 Option Exercise 0.00 20,153 0 125,315 Feb 18 06:00 PM D'Adamio Anthony SVP & General Counsel Feb 15 '25 Option Exercise 0.00 12,980 0 122,558 Feb 18 06:00 PM CHURCH KATRINA J SVP & Chief Compliance Officer Feb 15 '25 Option Exercise 0.00 4,375 0 51,639 Feb 18 05:59 PM Claypoole Robert E President and CEO Jan 13 '25 Sale 9.10 28,786 261,953 64,964 Jan 14 06:59 PM Claypoole Robert E Officer Jan 13 '25 Proposed Sale 9.55 33,000 315,150 Jan 13 09:16 PM Claypoole Robert E President and CEO Jan 10 '25 Option Exercise 0.00 93,750 0 93,750 Jan 13 05:24 PM Singleton Mark Leonard SVP & CFO Dec 23 '24 Sale 10.53 10,733 113,018 105,162 Dec 26 04:55 PM CHURCH KATRINA J SVP & Chief Compliance Officer Dec 23 '24 Sale 10.53 2,535 26,694 47,264 Dec 26 04:55 PM D'Adamio Anthony SVP & General Counsel Dec 23 '24 Sale 10.53 5,848 61,579 109,578 Dec 26 04:54 PM Singleton Mark Leonard Officer Dec 23 '24 Proposed Sale 11.15 19,000 211,850 Dec 23 05:37 PM CHURCH KATRINA J Officer Dec 23 '24 Proposed Sale 11.15 8,000 89,200 Dec 23 05:35 PM D'Adamio Anthony Officer Dec 23 '24 Proposed Sale 11.15 16,000 178,400 Dec 23 05:34 PM Singleton Mark Leonard SVP & CFO Dec 20 '24 Option Exercise 0.00 31,000 0 115,895 Dec 23 05:28 PM CHURCH KATRINA J SVP & Chief Compliance Officer Dec 20 '24 Option Exercise 0.00 8,600 0 49,799 Dec 23 05:28 PM D'Adamio Anthony SVP & General Counsel Dec 20 '24 Option Exercise 0.00 19,850 0 115,426 Dec 23 05:27 PM Bartholdson John A. Director Aug 16 '24 Buy 8.55 80,000 683,736 6,913,857 Aug 20 06:16 PM Bartholdson John A. Director Aug 19 '24 Buy 8.55 25,500 217,966 6,939,357 Aug 20 06:16 PM
